provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content

Portrazza

Used for Lung Cancer
Used for Lung Cancer

Portrazza (necitumumab) is a targeted anticancer medication used to treat non-small cell lung cancer (NSCLC). More specifically, it blocks a protein called epidermal growth factor receptor (EGFR) to prevent the growth and spread of cancer cells. Portrazza (necitumumab) is given intravenously (IV) by a healthcare provider at their office or an infusion center. Though it’s still approved by the FDA, Portrazza (necitumumab) isn't a recommended medication in the United States any longer because there are other treatments that work just as well or better and that don’t have as many side effects.

Last reviewed on May 23, 2023
basics-icon

What is Portrazza (necitumumab)?

How Portrazza (necitumumab) works

Drug Facts

Common BrandsPortrazza
Drug ClassEpidermal growth factor receptor (EGFR) inhibitor
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
faqs

Frequently asked questions about Portrazza (necitumumab)

What is Portrazza (necitumumab)?
Portrazza (necitumumab) is a targeted anticancer medication used to treat non-small cell lung cancer (NSCLC). It blocks a protein called the epidermal growth factor receptor (EGFR). Sometimes, EGFR sends signals to cancer cells that tell them to grow. So when we block this receptor with Portrazza (necitumumab), cancer cells can’t grow and spread as well. This medication is given with chemotherapy for up to 4 months. After that, your provider might continue treatment with Portrazza (necitumumab) by itself as long as it’s working and you’re not experiencing any serious side effects.
How is Portrazza (necitumumab) given?
Portrazza (necitumumab) is given intravenously at a provider’s office or infusion center. A healthcare provider will infuse the medication either through your arm or another access device, like a port. It’s usually given with chemotherapy once a week for two weeks, then you take a one week break. Typically, you’ll receive Portrazza (necitumumab) with chemotherapy for up to 4 months. After that, your provider will stop the chemotherapy and might continue to treat you with Portrazza (necitumumab) by itself depending on how this medication has been working for you.
Is Portrazza (necitumumab) still available?
Though it is still approved by the FDA, Portrazza (necitumumab) is no longer a recommended treatment option for NSCLC in the United States and not often prescribed. This is because there are other treatments that work just as well or better for NSCLC and that don’t have as many serious side effects.
What are common side effects of Portrazza (necitumumab)?
Portrazza (necitumumab) can commonly cause an acne-like skin rash on the face, upper back, and chest. This rash can be itchy and your provider might give you creams, lotions, or oral medications to help treat it. Portrazza (necitumumab) can also cause low blood levels of magnesium and your provider might prescribe magnesium supplements if your levels are too low. Let your provider know if you experience muscle cramps or muscle twitching because this could be a sign of low magnesium. In addition, you might experience other common side effects like nausea and vomiting, but these are more related to the chemotherapy that’s given with Portrazza (necitumumab).
What are serious or life threatening side effects of Portrazza (necitumumab)?
There are two black box warnings for Portrazza (necitumumab). The first is a risk of cardiac arrest and sudden death, which might be related to changes in blood levels of electrolytes like magnesium, potassium, and calcium. The second warning is specifically about low magnesium levels in the blood, which if severe enough, can lead to life-threatening heart rhythm problems. Your provider will order blood tests to check your electrolyte levels closely (usually once a week) during Portrazza (necitumumab) treatment and for at least 2 months after your last dose. They can prescribe magnesium supplements if your levels are too low. You can talk with your provider if you have more questions about the serious side effects of this medication.
GoodRxEducationalIcon

How to save using GoodRx

Compare Prices
1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
Select your free coupon
2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
Show coupon to your pharmacist
3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
Get free couponLearn more

Get savings updates for Portrazza (necitumumab)

Receive price alerts, news, and other messages from GoodRx about Portrazza (necitumumab) and other healthcare topics and relevant savings offers.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

References

Best studies we found

American Cancer Society. (2023). What is lung cancer?

Eli Lilly and Company. (2017). Portrazza - necitumumab solution [package insert]. DailyMed.

Lacouture, M. E., et al. (2011). Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Supportive Care in Cancer.

View All References (4)

National Cancer Institute. (n.d.). Epidermal growth factor receptor.

National Cancer Institute. (n.d.). Port.

National Cancer Institute. (2022). Targeted therapy to treat cancer.

National Comprehensive Cancer Network. (2023). Metastatic non-small cell lung cancer.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
Was this page helpful?

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.